Fukushima SiC Applied Engineering, a technology company, developing Boron Neutron Capture Therapy (BNCT) radiotherapy solutions, has raised $30m in Series C funding.

The round was joined by investors such as C:iz Investment, Japan Post Investment, Astellas Venture Management and SMBC Venture Capital.

The company plans to use the fund to support BNCT-related pre-clinical and clinical trial activities in Japan.

Additionally, the company will use the fund to accelerate its overseas activities, including efforts for regulatory approvals.

Fukushima SiC Applied Engineering developed an ultra-compact, multi-port neutron radiation cancer treatment system, using its proprietary SiC device technologies.

The system is more compact and cheaper compared to current BNCT systems.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

BNCT is a type of radiotherapy used for the treatment of cancer. The method uses a boron agent, which reacts with neutrons, and is accumulated by the tumour cells.

The tumour cells are selectively destroyed in the process, using the reaction between neutrons in a neutron beam and the accumulated boron.

Fukushima SiC Applied Engineering’s system has unique capabilities in targeting deep-seated cancers and metastatic micro tumours. It also has the ability to destroy tumour cells equivalent to heavy particle beam therapy.

Previously, these types of cancer were difficult to treat.

The technology development is partly funded by the Ministry of Economy, Trade and Industry subsidy programme for areas, recovering from the 2011 tsunami and nuclear disasters.

Fukushima SiC Applied Engineering focuses on the development and manufacturing of power electronics products, using SiC semiconductors, with the aim of contributing to the recovery from the earthquake.